Search Results

There are 119984 results for: content related to: Malignant melanoma and tumor necrosis factor-α inhibitors: a case report and review of the literature

  1. Tuberculosis and tumour necrosis factor-α inhibitor therapy: a report of three cases in patients with psoriasis. Comprehensive screening and therapeutic guidelines for clinicians

    British Journal of Dermatology

    Volume 160, Issue 1, January 2009, Pages: 8–15, A. Perlmutter, A. Mittal and A. Menter

    Version of Record online : 22 OCT 2008, DOI: 10.1111/j.1365-2133.2008.08891.x

  2. You have free access to this content
    Maternal and foetal adverse events with tumour necrosis factor-alpha inhibitors in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 9, November 2014, Pages: 1035–1043, P. Deepak and D. J. Stobaugh

    Version of Record online : 28 AUG 2014, DOI: 10.1111/apt.12936

  3. Using ‘number needed to treat’ to help conceptualize the magnitude of benefit and risk of tumour necrosis factor-α inhibitors for patients with severe psoriasis

    British Journal of Dermatology

    Volume 161, Issue 3, September 2009, Pages: 605–616, J.W. Dharamsi, M. Bhosle, R. Balkrishnan, B.A. Yentzer and S.R. Feldman

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1365-2133.2009.09158.x

  4. Risk of hepatitis B reactivation in patients treated with tumor necrosis factor-α inhibitors

    Hepatology Research

    Volume 42, Issue 4, April 2012, Pages: 333–339, Eiji Tanaka and Yukitomo Urata

    Version of Record online : 13 DEC 2011, DOI: 10.1111/j.1872-034X.2011.00937.x

  5. Self-reported outcomes during treatment with tumour necrosis factor α inhibitors in patients with rheumatoid arthritis

    Musculoskeletal Care

    Volume 8, Issue 1, March 2010, Pages: 27–35, Sidona-Valentina Bala, Kristina Forslind and Marie Edwinson Månsson

    Version of Record online : 6 NOV 2009, DOI: 10.1002/msc.163

  6. Inhibition of benzalkonium chloride-induced skin inflammation in mice by an indol-1-ylpropan-2-one inhibitor of cytosolic phospholipase A2α

    British Journal of Dermatology

    Volume 166, Issue 2, February 2012, Pages: 306–316, K. Roebrock, M. Wolf, S. Bovens, M. Lehr and C. Sunderkötter

    Version of Record online : 6 DEC 2011, DOI: 10.1111/j.1365-2133.2011.10637.x

  7. Clinical applicability of T-cell interferon-α release assay for tumour necrosis factor-α inhibitor therapy in severe psoriasis

    Clinical and Experimental Dermatology

    Volume 36, Issue 1, January 2011, Pages: 39–41, Y. Z. Chiang, K. Panting, B. Dever and R. A. G. Parslew

    Version of Record online : 27 APR 2010, DOI: 10.1111/j.1365-2230.2010.03850.x

  8. You have free access to this content
    Tumor necrosis factor α inhibitor therapy and cancer risk in chronic immune-mediated diseases

    Arthritis & Rheumatism

    Volume 65, Issue 1, January 2013, Pages: 48–58, Kevin Haynes, Timothy Beukelman, Jeffrey R. Curtis, Craig Newcomb, Lisa J. Herrinton, David J. Graham, Daniel H. Solomon, Marie R. Griffin, Lang Chen, Liyan Liu, Kenneth G. Saag, James D. Lewis and on behalf of the SABER Collaboration

    Version of Record online : 27 DEC 2012, DOI: 10.1002/art.37740

  9. You have free access to this content
    Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride

    Intervention Review

    The Cochrane Library

    Niels Albert Graudal, Thorbjorn Hubeck-Graudal and Gesche Jurgens

    Published Online : 9 NOV 2011, DOI: 10.1002/14651858.CD004022.pub3

  10. You have free access to this content
    Injectable Tumor Necrosis Factor α Inhibitors and Outpatient Antimicrobial Use in Children With Rheumatic Diseases: Analyses of Prescription Claims From a Pharmacy Benefit Manager Database

    Arthritis Care & Research

    Volume 65, Issue 11, November 2013, Pages: 1880–1884, Sarah Ringold, Shannon Grant, Charmaine Girdish, Carol A. Wallace and Sean D. Sullivan

    Version of Record online : 28 OCT 2013, DOI: 10.1002/acr.22053

  11. You have free access to this content
    The Impact of Tumor Necrosis Factor α Inhibitors on Radiographic Progression in Ankylosing Spondylitis

    Arthritis & Rheumatism

    Volume 65, Issue 10, October 2013, Pages: 2645–2654, Nigil Haroon, Robert D. Inman, Thomas J. Learch, Michael H. Weisman, MinJae Lee, Mohammad H. Rahbar, Michael M. Ward, John D. Reveille and Lianne S. Gensler

    Version of Record online : 24 SEP 2013, DOI: 10.1002/art.38070

  12. You have free access to this content
    Tumor Necrosis Factor α Inhibitor Use and Decreased Risk for Incident Coronary Events in Rheumatoid Arthritis

    Arthritis Care & Research

    Volume 66, Issue 3, March 2014, Pages: 355–363, Androniki Bili, Xiaoqin Tang, Shruthi Pranesh, Rasa Bozaite, Stephanie J. Morris, Jana L. Antohe, H. Lester Kirchner and Mary Chester M. Wasko

    Version of Record online : 24 FEB 2014, DOI: 10.1002/acr.22166

  13. You have full text access to this OnlineOpen article
    The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer

    Cancer Medicine

    Volume 3, Issue 2, April 2014, Pages: 245–251, Weranja K. B. Ranasinghe, Shomik Sengupta, Scott Williams, Mike Chang, Arthur Shulkes, Damien M. Bolton, Graham Baldwin and Oneel Patel

    Version of Record online : 27 JAN 2014, DOI: 10.1002/cam4.189

  14. Secondary syphilis following tumor necrosis factor-α inhibitor treatment for rheumatoid arthritis

    The Journal of Dermatology

    Volume 39, Issue 2, February 2012, Pages: 199–201, Akihiko ASAHINA, Norihisa ISHII and Shigeto TOHMA

    Version of Record online : 5 APR 2011, DOI: 10.1111/j.1346-8138.2011.01243.x

  15. You have free access to this content
    Infection Risk After Orthopedic Surgery in Patients With Inflammatory Rheumatic Diseases Treated With Immunosuppressive Drugs

    Arthritis Care & Research

    Volume 65, Issue 12, December 2013, Pages: 2032–2040, Catrina B. Scherrer, Anne F. Mannion, Diego Kyburz, Markus Vogt and Inès A. Kramers-de Quervain

    Version of Record online : 27 NOV 2013, DOI: 10.1002/acr.22077

  16. An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease

    Journal of the European Academy of Dermatology and Venereology

    Volume 24, Issue 5, May 2010, Pages: 578–586, A Marchesoni, G Altomare, M Matucci-Cerinic, N Balato, I Olivieri, C Salvarani, T Lotti, R Scarpa, GA Vena, G Valesini and A Giannetti

    Version of Record online : 23 OCT 2009, DOI: 10.1111/j.1468-3083.2009.03474.x

  17. You have free access to this content
    Biologics in oral medicine: principles of use and practical considerations

    Oral Diseases

    Volume 18, Issue 6, September 2012, Pages: 525–536, ID O’Neill and C Scully

    Version of Record online : 15 MAR 2012, DOI: 10.1111/j.1601-0825.2012.01919.x

  18. Cytokines as Targets for Anti-inflammatory Agents

    Annals of the New York Academy of Sciences

    Volume 1182, Issue 1, December 2009, Pages: 88–96, Larry W. Moreland

    Version of Record online : 10 DEC 2009, DOI: 10.1111/j.1749-6632.2009.05072.x

  19. Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study

    British Journal of Clinical Pharmacology

    Volume 80, Issue 4, October 2015, Pages: 727–739, Corinna Weber-Schoendorfer, Marc Oppermann, Evelin Wacker, Nathalie Bernard, on behalf of the network of French pharmacovigilance centres, Delphine Beghin, Benedikte Cuppers-Maarschalkerweerd, Jonathan L. Richardson, Laura E. Rothuizen, Alessandra Pistelli, Heli Malm, Georgios Eleftheriou, Debra Kennedy, Mine Kadioglu Duman, Reinhard Meister and Christof Schaefer

    Version of Record online : 28 MAY 2015, DOI: 10.1111/bcp.12642

  20. Alfalfa, rice by-products and their incorporation for weed control in rice

    Weed Biology and Management


    Version of Record online : 29 MAY 2003, DOI: 10.1046/j.1445-6664.2003.00095.x